<DOC>
	<DOCNO>NCT01430559</DOCNO>
	<brief_summary>This study validate Western Ontario McMaster Universities Osteoarthritis Index ( WOMAC ) tool mainland Chinese patient osteoarthritis knee . This study also evaluate effect Mobic versus placebo reduce symptom osteoarthritis population .</brief_summary>
	<brief_title>Effect Of Meloxicam Versus Placebo In Mainland Chinese Patients With Osteoarthritis Of The Knee</brief_title>
	<detailed_description>To validate culturally WOMAC tool mainland China observe different response meloxicam placebo patient population osteoarthritis knee</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Meloxicam</mesh_term>
	<criteria>Subjects require meet follow criterion eligible Randomization study : Male female Chinese subject , 1875 year age ; Subjects must diagnosis OA index knee base American College Rheumatology criterion X ray confirmation ( Kellgren Lawrence x ray grade great equal 2 ) ( Kellgren J . &amp; Lawrence J , 1957 ) Subjects must NRS WOMAC pain sub scale score 4 Screening Baseline base four daily diary entry Subjects present follow include study : History disease may involve index ( painful ) knee include inflammatory joint disease recent surgical intervention knee . Diagnosed treated esophageal , gastric , pyloric channel , duodenal ulceration within 30 day prior receive first dose study medication . History active gastrointestinal disease ( eg , inflammatory bowel disease ) , chronic acute renal hepatic disorder , significant coagulation defect . Signs symptom clinically significant cardiac disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Validation WOMAC Chinese subject osteoarthritis knee</keyword>
</DOC>